Retrospective Study
Copyright ©The Author(s) 2023.
World J Gastroenterol. Apr 21, 2023; 29(15): 2322-2335
Published online Apr 21, 2023. doi: 10.3748/wjg.v29.i15.2322
Table 3 Multiple logistics regression analysis for each group and the control group
Part
Variable
B
SE
Wald
P
OR (95%Cl)
Part IRDW (%)0.7770.17320.141 < 0.0012.175 (1.549, 3.054)
TBIL (μmol/L)-0.0860.0512.810 0.094 0.918 (0.83, 1.015)
ALB (g/L)-0.0600.0352.973 0.085 0.942 (0.879, 1.008)
ALT (IU/L)0.1220.0673.350 0.067 1.129 (0.991, 1.287)
AST (IU/L)-0.1080.0603.178 0.075 0.898 (0.798, 1.011)
γ-GT (IU/L)0.0040.0110.117 0.733 1.004 (0.982, 1.026)
WBC count (× 109/L)0.0260.1070.059 0.808 1.026 (0.832, 1.265)
Hemoglobin (g/L)0.0120.0101.294 0.255 1.012 (0.992, 1.032)
Platelet count (× 109/L)-0.0060.0033.638 0.056 0.994 (0.988, 1.000)
INR0.4180.2902.074 0.150 1.519 (0.86, 2.683)
NT-proBNP (pg/mL)0.0010.0020.417 0.518 1.001 (0.997, 1.005)
eGFR (mL/min/1.73 m2)-0.0090.0120.598 0.439 0.991 (0.967, 1.015)
Hyperlipidemia-0.074 0.346 0.046 0.831 0.929 (0.471, 1.830)
Atrial fibrillation-0.402 0.602 0.448 0.503 0.669 (0.206, 2.174)
Haematemesis-0.730 0.711 1.054 0.305 0.482 (0.12, 1.942)
Edema0.105 1.196 0.008 0.930 1.111 (0.107, 11.580)
SBP1.623 2.242 0.524 0.469 5.07 (0.063, 410.934)
Hyponatremia-1.682 0.934 3.243 0.072 0.186 (0.030, 1.16)
Hepatic encephalopathy-0.161 0.804 0.040 0.842 0.852 (0.176, 4.119)
Jaundice-1.044 1.264 0.683 0.409 0.352 (0.030, 4.188)
Refractory ascites0.256 1.498 0.029 0.864 1.292 (0.069, 24.324)
Part IIRDW (%)0.895 0.294 9.265 0.002 2.447 (1.375, 4.354)
TBIL (μmol/L)-0.028 0.083 0.116 0.733 0.972 (0.825, 1.145)
ALB (g/L)-0.723 0.140 26.552 < 0.0010.485 (0.369, 0.639)
ALT (IU/L)0.337 0.087 15.167 < 0.0011.401 (1.182, 1.660)
AST (IU/L)-0.390 0.087 19.883 < 0.0010.677 (0.571, 0.804)
γ-GT (IU/L)0.037 0.018 4.313 0.038 1.037 (1.002, 1.074)
WBC count (× 109/L)0.592 0.253 5.464 0.019 1.807 (1.100, 2.969)
Hemoglobin (g/L)-0.057 0.026 4.929 0.026 0.944 (0.898, 0.993)
Platelet count (× 109/L)-0.055 0.010 32.104 < 0.0010.947 (0.929, 0.965)
INR1.894 0.563 11.321 0.001 6.643 (2.205, 20.018)
NT-proBNP (pg/mL)0.008 0.003 8.203 0.004 1.008 (1.003, 1.014)
eGFR (mL/min/1.73 m2)0.062 0.027 5.365 0.021 1.064 (1.010, 1.121)
Hyperlipidemia-1.173 0.658 3.174 0.075 0.309 (0.085, 1.125)
Atrial fibrillation0.365 1.006 0.132 0.717 1.441 (0.201, 10.345)
Haematemesis2.282 1.499 2.318 0.128 9.792 (0.519, 184.678)
Edema3.004 1.778 2.855 0.091 20.159 (0.618, 657.095)
SBP4.715 4.750 0.985 0.321 111.572 (0.010, 1231574.165)
Hyponatremia-0.424 1.259 0.113 0.736 0.655 (0.055, 7.724)
Hepatic encephalopathy-1.850 1.290 2.057 0.151 0.157 (0.013, 1.970)
Jaundice1.862 2.392 0.606 0.436 6.437 (0.059, 699.588)
Refractory ascites-1.431 3.819 0.140 0.708 0.239 (0, 425.671)
Part IIIRDW (%)1.582 0.341 21.541 < 0.0014.863 (2.493, 9.483)
TBIL (μmol/L)-0.080 0.090 0.787 0.375 0.923 (0.774, 1.101)
ALB (g/L)-0.910 0.150 37.020 < 0.0010.402 (0.300, 0.539)
ALT (IU/L)0.350 0.087 16.273 < 0.0011.419 (1.197, 1.682)
AST (IU/L)-0.410 0.088 21.725 < 0.0010.664 (0.559, 0.789)
γ-GT (IU/L)0.032 0.018 3.226 0.072 1.033 (0.997, 1.070)
WBC count (× 109/L)0.763 0.292 6.798 0.009 2.144 (1.208, 3.803)
Hemoglobin (g/L)-0.070 0.029 5.697 0.017 0.932 (0.880, 0.988)
Platelet count (× 109/L)-0.077 0.013 35.070 < 0.0010.926 (0.902, 0.950)
INR1.828 0.621 8.661 0.003 6.224 (1.842, 21.031)
NT-proBNP (pg/mL)0.008 0.003 7.937 0.005 1.008 (1.002, 1.014)
eGFR (mL/min/1.73 m2)-0.005 0.033 0.018 0.892 0.995 (0.932, 1.063)
Hyperlipidemia-0.404 0.764 0.280 0.5970.667 (0.149, 2.986)
Atrial fibrillation0.417 1.132 0.135 0.7131.517 (0.165, 13.954)
Haematemesis3.164 1.693 3.493 0.06223.67 (0.857, 653.530)
Edema3.826 1.882 4.132 0.04245.891 (1.147, 1836.043)
SBP5.570 4.815 1.339 0.247262.503 (0.021, 3291299.144)
Hyponatremia-0.376 1.364 0.076 0.7830.687 (0.047, 9.940)
Hepatic encephalopathy-1.949 1.468 1.763 0.1840.142 (0.008, 2.530)
Jaundice0.527 2.529 0.043 0.8351.694 (0.012, 240.821)
Refractory ascites-0.538 3.896 0.019 0.8900.584 (0, 1210.714)